Researchers have developed an inexpensive blood test they say can predict a pregnant women’s due date and potentially identify women at risk for of preterm birth; Virginia's governor has expanded Medicaid in the state; and the American Medical Association is expected to take a stance on over-the-counter birth control this weekend.
Scientists have developed a blood test they say can be used to predict a pregnant woman’s due date and potentially identify women at risk for giving birth prematurely. The New York Times reported that the research, which is still in preliminary stages, detects changes in RNA in a pregnant woman’s blood and can estimate due dates within 2 weeks in nearly half the cases. According to researchers, the inexpensive test is as accurate as ultrasound, the current and more expensive method.
Virginia Governor Ralph Northam has signed off on a budget that includes Medicaid expansion for the state. According to The Hill, the expansion is estimated to provide health insurance to up to 400,000 people. The expansion includes work requirements for Medicaid recipients and marks the 33rd state to expand Medicaid.
As pressure mounts for drug makers to sell birth control over the counter, the American Medical Association (AMA) is expected to take a stance on the issue during its annual meeting in Chicago this weekend, reported STAT News. According to the news outlet, delegates from nation’s largest physicians group are expected to vote on a resolution to encourage birth control manufacturers to submit applications to the FDA to switch the status of their pills from prescription to over the counter.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More